A Retrospective Study to Evaluate the Effectiveness of onabotulinumtoxinA in Preventing Headaches in Patients With Chronic Migraines
Withdrawn prior to enrolment
Phase of Trial: Phase IV
Latest Information Update: 31 Jan 2014
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Headache; Migraine
- Focus Therapeutic Use
- Sponsors Allergan
- 31 Jan 2014 According to ClinicalTrials.gov record trial status changed from suspended to withdrawn prior to recruitment.
- 13 Jun 2013 Planned end date changed from 1 Mar 2013 to 1 Dec 2013 as reported by ClinicalTrials.gov.
- 13 Jun 2013 Status changed from recruiting to suspended as reported by ClinicalTrials.gov.